Rhaeos is a clinical stage digital health and medical technology company developing FlowSense, a platform noninvasive wireless, wearable skin sensor that can assess bodily fluid flow beneath the skin’s surface in the hospital and home. The company is initially targeting hydrocephalus, a chronic neurological condition caused by an abnormal accumulation of cerebrospinal fluid (CSF) on the brain. Pipeline applications in oncology and dialysis are in development.